Genialis, Inc.

BOSTON, MA · CIK 0001948756 · Biotech · Private

Software platform for analyzing genomic and clinical data to guide precision oncology drug development

genialis.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$12M
2 Form D · Dec 2025
9 months since last filing
Contracts
—
No federal contracts on record
Patents
9
0 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$11,423,253
Private capital raisedForm D · SEC$700,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2482DMC Limited——
2483Curie Co. Inc.—$13M
2484Incannex Healthcare Inc.—$12M
2485Genialis, Inc.—$12M
2486Borealis Biosciences——
2487PANOME BIO INC—$12M
2488ANAVEX LIFE SCIENCES CORP.—$11M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Hamzeh Abdul-HadiDirector
  • Luka AusecExecutive Officer
  • Nadine GeiserDirector
  • Tjasa KutinExecutive Officer
  • Ita LuDirector
  • Krista McKerracherDirector
  • Cedric OdjeDirector
  • Rafael RosengartenDirector · Executive Officer
  • Miha StajdoharDirector · Executive Officer
  • Elia StupkaDirector
  • Drew VolpeDirector

Patents

USPTO · 0 granted of 9
  • System Of Preprocessors To Harmonize Disparate 'omics Datasets By Addressing Bias And/or Batch Effectsapplication
  • Evaluating The Robustness And Transferability Of Predictive Signatures Across Molecular Biomarker Datasetsapplication
  • Prediction Of Tumor Response And Clinical Benefit From Kras Therapeutic Agentsapplication
  • System Of Preprocessors To Harmonize Disparate 'omics Datasets By Addressing Bias And/or Batch Effectsapplication
  • System Of Preprocessors To Harmonize Disparate 'omics Datasets By Addressing Bias And/or Batch Effectsapplication
  • Evaluating The Robustness And Transferability Of Predictive Gene Signatures Across Genomic Datasetsapplication
  • Prediction Of Tumor Response And Clinical Benefit From Kras Therapeutic Agentsapplication
  • Evaluating The Robustness And Transferability Of Predictive Gene Signatures Across Genomic Datasetsapplication
  • Prediction Of Tumor Response And Clinical Benefit From Kras Therapeutic Agentsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.